---
figid: PMC5267440__13024_2017_154_Fig1_HTML
figtitle: Molecular regulation of macroautophagy and targets for pharmacological stimulation
  of the autophagy-lysosomal pathway
organisms:
- Mus musculus
- Rattus norvegicus
- Saccharomyces cerevisiae
- Drosophila melanogaster
- Caenorhabditis elegans
- Chenopodium album
- Homo sapiens
- Adeno-associated virus
- Streptomyces hygroscopicus
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Danio rerio
pmcid: PMC5267440
filename: 13024_2017_154_Fig1_HTML.jpg
figlink: /pmc/articles/PMC5267440/figure/Fig1/
number: F1
caption: Molecular regulation of macroautophagy and targets for pharmacological stimulation
  of the autophagy-lysosomal pathway. Situations of amino acid deprivation and low
  amounts of energy, detected by AMPK, can lead to the inhibition of mTORC1, resulting
  in the initiation of autophagy via activation of the ULK1-FIP200-Atg13 complex.
  In this situation, TFEB is dephosphorylated and translocates to the cell nucleus
  where it binds to ATGs to activate de novo gene transcription. Deprivation of growth
  factors or insulin results in reduced activation of the PI3K Class 1 complex, which
  promotes the formation of autophagosomes via activation of the Beclin-1-VSP34 complex.
  A final mTOR-independent pathway, involving the generation of IP3, acts as a negative
  regulator of autophagy. A number of autophagy-enhancing agents, shown in red, is
  yet available, allowing to act at different levels of the autophagy-lysosomal pathway
papertitle: Therapeutic potential of autophagy-enhancing agents in Parkinsonâ€™s disease.
reftext: Tim E. Moors, et al. Mol Neurodegener. 2017;12:11.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9651079
figid_alias: PMC5267440__F1
figtype: Figure
redirect_from: /figures/PMC5267440__F1
ndex: 76e3d662-ded3-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5267440__13024_2017_154_Fig1_HTML.html
  '@type': Dataset
  description: Molecular regulation of macroautophagy and targets for pharmacological
    stimulation of the autophagy-lysosomal pathway. Situations of amino acid deprivation
    and low amounts of energy, detected by AMPK, can lead to the inhibition of mTORC1,
    resulting in the initiation of autophagy via activation of the ULK1-FIP200-Atg13
    complex. In this situation, TFEB is dephosphorylated and translocates to the cell
    nucleus where it binds to ATGs to activate de novo gene transcription. Deprivation
    of growth factors or insulin results in reduced activation of the PI3K Class 1
    complex, which promotes the formation of autophagosomes via activation of the
    Beclin-1-VSP34 complex. A final mTOR-independent pathway, involving the generation
    of IP3, acts as a negative regulator of autophagy. A number of autophagy-enhancing
    agents, shown in red, is yet available, allowing to act at different levels of
    the autophagy-lysosomal pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - ca
  - Akt
  - gig
  - norpA
  - sl
  - Plc21C
  - cd
  - Pcd
  - Debcl
  - Atg6
  - SNF4Agamma
  - AMPKalpha
  - Mitf
  - inc
  - insc
  - InR
  - raptor
  - Crtc
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Atg17
  - Atg1
  - Galphas
  - Atg13
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - TSC2
  - ATIC
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - DNAH5
  - PCBD1
  - DNAI1
  - DNAAF3
  - BCL2
  - BECN1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - TFEB
  - IKBKG
  - MTOR
  - RPTOR
  - RB1CC1
  - ULK1
  - GNAS
  - GNAL
  - ATG13
  - Pik3r1
  - Akt1
  - Tsc2
  - Hspg2
  - Pcbd1
  - Agtpbp1
  - Bcl2
  - Tfeb
  - Rptor
  - Rb1cc1
  - Ulk1
  - Gnas
  - Pik3cg
  - Becn1
  - Prkaa2
  - tsc2
  - bcl2a
  - tfeb
  - ins
  - ulk1b
  - atg13
  - Carbamazepine
  - Glucose
  - Metformin
  - Sodium Valproate
  - Rapamycin
  - Cancer
---
